Wuhan Dgensee Medical Laboratory Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 1,200,000 on January 26, 2022. The transaction will include participation from new investors Shenzhen YHLO Biotech Co., Ltd. for CNY 825,413, Shenzhen Puhui Zhonglian Industrial Investment Co., Ltd. for CNY 277,472, Yao Yiyu for CNY 97,115. The transaction has been approved at the 4th session, the 3rd directorate and the 4th session of the 3rd supervisory board of Shenzhen YHLO Biotech Co., Ltd. Post the closing, the registered capital of the company will increase from CNY 13,000,000 to CNY 14,200,000.